Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR’s Advocacy Leadership Conference Brings Volunteers to Washington, D.C.

Staff  |  Issue: July 2014  |  July 1, 2014

From left: Eric L. Matteson, MD; Sen. Amy Klobuchar (D-Minn.); Timothy Laing, MD; and Gary Bryant, MD.
From left: Eric L. Matteson, MD; Sen. Amy Klobuchar (D-Minn.); Timothy Laing, MD; and Gary Bryant, MD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Advocacy Leadership Conference

The ACR Board of Directors, Government Affairs Committee, RheumPAC Committee and Affiliate Society Council converged on Washington, D.C., last month to participate in the annual Advocacy Leadership Conference.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

During the conference, attendees heard from John Pilotte, who leads the Performance-Based Payment Policy Group at CMS. Mr. Pilotte discussed the value-based payment modifier and PQRS reporting and received input from rheumatology leaders. The conference also included an update on cognitive specialty issues on Capitol Hill by Mike Amery with the American Academy of Neurology. The group then took to Capitol Hill, where they met with representatives of more than 90 congressional offices and advocated for important issues facing rheumatology. The top issues addressed were patient access to critical treatments, funding for research, work force issues, DXA payment rates, and Medicare Part B drug reimbursements.

You can help advance rheumatology and ensure patients’ continued access to quality care.

The ACR encourages all members to help advance rheumatology by scheduling a local meeting to educate your lawmakers about advocacy priorities. Members of Congress have regular district work periods when they are available to meet with constituents in their local offices. This is an important opportunity to provide information and build relationships. Please consider scheduling a meeting during the upcoming district work period: Aug. 4–Sept. 5. If you would like assistance scheduling or preparing for a meeting or would like to share your experiences meeting with lawmakers, contact ACR staff at [email protected] or 404-633-3777.

Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RACR Board of DirectorsAdvocacyAffiliate Society Council (ASC)American College of Rheumatology (ACR)LegislationPQRSRheumPAC Committee

Related Articles

    Optimize Patient Scheduling

    March 8, 2012

    Optimizing patient schedules is a continuous process that is critical to physician efficiency and satisfied patients. Taking inventory of the scheduling trends in your practice can have a positive influence on tackling appointment templates, which determines patient flow that affects your revenue.

    Advocacy Leadership Conference: Reflections from an Accidental Rheumatology Advocate

    May 19, 2022

    At my first Advocacy Leadership Conference as a member of the ACR’s Insurance Subcommittee, I discovered the power of stories from the clinic and how lawmakers value clinicians’ input on healthcare legislation.

    In Advocacy, Slow and Steady Wins the Race

    April 1, 2010

    Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

    Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology

    October 10, 2016

    Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences